Chapter 52 Transfusion Therapy for Coagulation Factor Deficiencies
qod, Every other day.
† Painless spontaneous hematuria often requires no treatment other than fluid intake. Persistence requires treatment and evaluation.
‡ Use of a schedule of 25 U/kg qod and a dose of 40 U/kg with an interval of 2 days between the next dose may increase compliance by decreasing infusions to three per week.
Data from DiMichele D: Hemophilia 1996. New approach to an old disease. Pediatr Clin North Am 43:709, 1996; Mannucci PM: Haemophilia treatment protocols around the world: Towards a consensus. Haemophilia 4:421, 1998; and Lusher J: Treatment of congenital coagulopathies, 1999, AABB Press.
1-Deamino 8-D Arginine Vasopressin Trial
1. Collect citrated plasma from the patient immediately before DDAVP infusion for testing with the postinfusion blood specimen.
2. Administer DDAVP intravenously (0.3 µg/1 kg) in 25 to 50 mL normal saline.